Get the Stockscreener App
7.36
4.29%
-0.33
Quantum Biopharma Ltd stock is traded at $7.36, with a volume of 74,445.
It is down -4.29% in the last 24 hours and down -7.94% over the past month.
Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.
See More
Previous Close:
$7.69
Open:
$7.58
24h Volume:
74,445
Relative Volume:
0.38
Market Cap:
$28.08M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-17.40%
1M Performance:
-7.94%
6M Performance:
+79.08%
1Y Performance:
+180.92%
1-Day Range:
$6.825
$7.6381
1-Week Range:
$6.825
$9.1975
52-Week Range:
$1.35
$19.12
Quantum Biopharma Ltd Stock (QNTM) Company Profile
Compare QNTM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QNTM
Quantum Biopharma Ltd
|
7.36 | 29.35M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.15 | 110.25B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
693.50 | 73.04B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.16 | 59.98B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
907.98 | 54.90B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.22 | 40.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Quantum Biopharma Ltd Stock (QNTM) Latest News
Why Quantum BioPharma Ltd. stock attracts high net worth investors2025 Technical Patterns & Long-Term Growth Portfolio Plans - newser.com
Real time scanner hits for Quantum BioPharma Ltd. explainedJuly 2025 Movers & Safe Capital Growth Trade Ideas - newser.com
Full technical analysis of Quantum BioPharma Ltd. stockJuly 2025 Institutional & Safe Capital Investment Plans - newser.com
Quantum BioPharma Ltd. stock volume spike explainedSell Signal & Real-Time Buy Zone Alerts - newser.com
How Quantum BioPharma Ltd. stock benefits from strong dollarCPI Data & Comprehensive Market Scan Insights - newser.com
Will Quantum BioPharma Ltd. stock go up soonWeekly Loss Report & Weekly Sector Rotation Insights - newser.com
Will Quantum BioPharma Ltd. stock split attract more investorsQuarterly Profit Report & Real-Time Buy Signal Notifications - newser.com
Custom watchlist performance reports with Quantum BioPharma Ltd.Market Trend Report & Capital Efficiency Focused Strategies - newser.com
How to read the order book for Quantum BioPharma Ltd.Market Movement Recap & AI Powered Market Entry Strategies - newser.com
Will Quantum BioPharma Ltd. (0K91) stock announce a stock split2025 Investor Takeaways & Safe Capital Growth Plans - newser.com
Is Quantum BioPharma Ltd. stock a top pick in earnings seasonMarket Risk Summary & Risk Managed Investment Strategies - newser.com
Can Quantum BioPharma Ltd. stock beat analyst upgrades2025 Big Picture & AI Forecasted Stock Moves - newser.com
Can Mukand Limited Deliver on Promised Growth AmbitionsShort Interest Overview & Easy Tools to Analyze Your Investment Risk - earlytimes.in
Can Tembo Global Industries Limited Maintain Shareholder Returns via BuybacksInsider Selling Patterns & Budget Friendly Stock Tips - earlytimes.in
Predicting Quantum BioPharma Ltd. trend using moving averagesMarket Trend Report & Weekly Market Pulse Alerts - newser.com
Order flow analysis tools used on Quantum BioPharma Ltd.Share Buyback & Stock Portfolio Risk Management - newser.com
Quantum BioPharma sees cash runway beyond March 2027 - TipRanks
Quantum BioPharma reports Q3 EPS ($1.25) vs. (4.37) last year - TipRanks
Quantum Biopharma Ltd expected to post a loss of 22 cents a shareEarnings Preview - TradingView
How to monitor Quantum BioPharma Ltd. with trend dashboardsJuly 2025 Outlook & Daily Growth Stock Investment Tips - newser.com
Quantum BioPharma (QNTM) Strengthens Operations and Financial Po - GuruFocus
QNTM Digital Assets Surge as Company Strengthens Financial Position - GuruFocus
Quantum BioPharma Reports Strong Q3 2025 Results and Advances MS Drug Trials - TipRanks
Quantum Biopharma Reports Strong Third Quarter Results Maintaining ‘No Going Concern’ Status with Cash Runway Extending Beyond March 2027, and $572,000 USD Gains in Crypto Portfolio - The Manila Times
How strong is Quantum BioPharma Ltd. stock revenue growthIndex Update & Reliable Price Breakout Alerts - newser.com
Will Quantum BioPharma Ltd. stock sustain high P E ratios2025 Trading Volume Trends & Daily Growth Stock Investment Tips - newser.com
Quantum Biopharma Reports Q3 2025 Financial Results - TipRanks
Is Quantum BioPharma Ltd. stock supported by strong fundamentals2025 Valuation Update & Fast Exit Strategy with Risk Control - newser.com
Tools to assess Quantum BioPharma Ltd.’s risk profileEarnings Summary Report & AI Driven Price Predictions - newser.com
How Quantum BioPharma Ltd. (0K91) stock correlates with oil marketsOptions Play & Weekly Breakout Watchlists - newser.com
Quantum Biopharma Ltd Stock (QNTM) Financials Data
There is no financial data for Quantum Biopharma Ltd (QNTM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.43%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):